Literature DB >> 21584675

Image evaluation of HIV encephalopathy: a multimodal approach using quantitative MR techniques.

Paulo T C Prado1, Sara Escorsi-Rosset, Maria C Cervi, Antonio Carlos Santos.   

Abstract

INTRODUCTION: A multimodal approach of the human immunodeficiency virus (HIV) encephalopathy using quantitative magnetic resonance (MR) techniques can demonstrate brain changes not detectable only with conventional magnetic resonance imaging (MRI). The aim of this study was to compare conventional MRI and MR quantitative techniques, such as magnetic resonance spectroscopy (MRS) and relaxometry and to determine whether quantitative techniques are more sensitive than conventional imaging for brain changes caused by HIV infection.
METHODS: We studied prospectively nine HIV positive children (mean age 6 years, from 5 to 8 years old) and nine controls (mean age 7.3 years; from 3 to 10 years), using MRS and relaxometry. Examinations were carried on 1.5-T equipment.
RESULTS: HIV-positive patients presented with only minor findings and all control patients had normal conventional MR findings. MRS findings showed an increase in choline to creatine (CHO/CRE) ratios bilaterally in both frontal gray and white matter, in the left parietal white matter, and in total CHO/CRE ratio. In contrast, N-acetylaspartate to creatine (NAA/CRE) ratios did not present with any significant difference between both groups. Relaxometry showed significant bilateral abnormalities, with lengthening of the relaxation time in HIV positive in many regions.
CONCLUSION: Conventional MRI is not sensitive for early brain changes caused by HIV infection. Quantitative techniques such as MRS and relaxometry appear as valuable tools in the diagnosis of these early changes. Therefore, a multimodal quantitative study can be useful in demonstrating and understanding the physiopathology of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584675     DOI: 10.1007/s00234-011-0869-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  48 in total

1.  Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.

Authors:  A M Salvan; J Vion-Dury; S Confort-Gouny; F Nicoli; S Lamoureux; P J Cozzone
Journal:  Invest Radiol       Date:  1997-08       Impact factor: 6.016

Review 2.  Pathology of HIV-1 infection of the central nervous system. A review.

Authors:  L R Sharer
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

Review 3.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

4.  Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation.

Authors:  H S Chrysikopoulos; G A Press; M R Grafe; J R Hesselink; C A Wiley
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

5.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy.

Authors:  J Vion-Dury; F Nicoli; A M Salvan; S Confort-Gouny; C Dhiver; P J Cozzone
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

6.  Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course.

Authors:  M M Thurnher; E G Schindler; S A Thurnher; H Pernerstorfer-Schön; C Kleibl-Popov; A Rieger
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

7.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.

Authors:  D J Meyerhoff; C Bloomer; V Cardenas; D Norman; M W Weiner; G Fein
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

8.  Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS.

Authors:  D Lu; S G Pavlakis; Y Frank; S Bakshi; S Pahwa; R J Gould; C Sison; C Hsu; M Lesser; M Hoberman; T Barnett; R A Hyman
Journal:  Radiology       Date:  1996-05       Impact factor: 11.105

9.  Magnetic resonance spectroscopy in childhood AIDS encephalopathy.

Authors:  S G Pavlakis; D Lu; Y Frank; S Bakshi; S Pahwa; T A Barnett; M E Porricolo; R J Gould; M L Nozyce; R A Hyman
Journal:  Pediatr Neurol       Date:  1995-05       Impact factor: 3.372

10.  Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis.

Authors:  G J Dal Pan; J H McArthur; E Aylward; O A Selnes; T E Nance-Sproson; A J Kumar; E D Mellits; J C McArthur
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

View more
  9 in total

Review 1.  Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents.

Authors:  Jacqueline Hoare; Gabrielle L Ransford; Nicole Phillips; Taryn Amos; Kirsten Donald; Dan J Stein
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

Review 2.  HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

3.  White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy.

Authors:  Christelle Ackermann; Savvas Andronikou; Barbara Laughton; Martin Kidd; Els Dobbels; Steve Innes; Ronald van Toorn; Mark Cotton
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

4.  Multivariate approach for longitudinal analysis of brain metabolite levels from ages 5-11 years in children with perinatal HIV infection.

Authors:  Noëlle van Biljon; Frances Robertson; Martha Holmes; Mark F Cotton; Barbara Laughton; Andre van der Kouwe; Ernesta Meintjes; Francesca Little
Journal:  Neuroimage       Date:  2021-05-04       Impact factor: 6.556

5.  HIV Encephalopathy: pediatric case series description and insights from the clinic coalface.

Authors:  Kirsten A Donald; Kathleen G Walker; Tracy Kilborn; Henri Carrara; Nelleke G Langerak; Brian Eley; Jo M Wilmshurst
Journal:  AIDS Res Ther       Date:  2015-01-17       Impact factor: 2.250

6.  Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.

Authors:  Yvonne W Van Dalen; Charlotte Blokhuis; Sophie Cohen; Jacqueline A Ter Stege; Charlotte E Teunissen; Jens Kuhle; Neeltje A Kootstra; Henriette J Scherpbier; Taco W Kuijpers; Peter Reiss; Charles B L M Majoie; Matthan W A Caan; Dasja Pajkrt
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infection.

Authors:  Amy S Graham; Martha J Holmes; Francesca Little; Els Dobbels; Mark F Cotton; Barbara Laughton; Andre van der Kouwe; Ernesta M Meintjes; Frances C Robertson
Journal:  Neuroimage Clin       Date:  2020-11-19       Impact factor: 4.881

8.  White Matter Microstructural Integrity and Neurobehavioral Outcome of HIV-Exposed Uninfected Neonates.

Authors:  Linh T Tran; Annerine Roos; Jean-Paul Fouche; Nastassja Koen; Roger P Woods; Heather J Zar; Katherine L Narr; Dan J Stein; Kirsten A Donald
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

9.  Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years.

Authors:  Frances C Robertson; Martha J Holmes; Mark F Cotton; Els Dobbels; Francesca Little; Barbara Laughton; André J W van der Kouwe; Ernesta M Meintjes
Journal:  Front Hum Neurosci       Date:  2018-05-07       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.